The debate about essential-medicine pricing and access in India illustrates the difficulties inherent in establishing policies that serve conflicting public interests in achieving goals such as caring well and ensuring safety for all, while also pursuing financially-sustainable success in scientific innovation and trade. It highlights problems facing those interested in continuing drug and vaccines development and ensuring that, once marketed, such products contribute effectively to improving public health. Modern pharmaceuticals...

-Reuters NEW DELHI (TrustLaw) - About 60 percent of Indian women have no access to family planning services, giving them little control over their bodies and slowing efforts to boost human development indicators, said the head of the U.N. Population Fund (UNFPA). Human development indicators cover health, education and Living Standards. India, Asia's third-largest economy, is set to overtake China as the world's most populous nation by 2030. But, despite its impressive economic...

-Daily News Asia's rapid growth is leaving millions behind, causing a widening gap between rich and poor that threatens to undermine the region's stability, according to a new report from the Asian Development Bank (ADB). "Another 240 million people could have been lifted out of poverty over the past 20 years if inequality had remained stable instead of increasing as it has since the 1990s," said ADB's Chief Economist Changyong Rhee. The Asian...

-The Times of India   The RTE Act is an opportunity to break gender, caste, class and community barriers that threaten to damage the social fabric of our democracy and create fissures that could be ruinous to the country, writes Union HRD minister Kapil Sibal. The Supreme Court judgment upholding the constitutional validity of the Right of Children to Free and Compulsory Education (RTE) Act has once again focused public attention on education....

The country is clearly shaping its legislation to promote access to medicines by fostering generic production. INDIA'S approach to the revision of its Patents Act in 2005 is a clear example of a country shaping its legislation to promote access to medicines by fostering generic production. Although World Trade Organisation (WTO) rules made it mandatory for India to put in place a patent regime for medicines by 2005, nothing obliges...